Office of Global Policy and Strategy Leadership
Associate Commissioner for Global Policy and Strategy
Mark Abdoo is the Associate Commissioner for Global Policy and Strategy, providing executive oversight, strategic leadership and policy direction to FDA’s global policy, operations, trade, and diplomacy activities.
Mr. Abdoo joined the FDA in 2013 as the inaugural director of the Office of Public Health and Trade. In 2015, he took up the role of Associate Commissioner for Regulatory Policy, and in 2017 became Deputy Commissioner for Global Regulatory Operations and Policy (acting).
Prior to his tenure at the FDA, Mr. Abdoo served in other senior positions in the Federal government including: Senior Advisor in the Bureau for Food Security at the U.S. Agency for International Development, Director for Global Health and Food Security at the National Security Council, and in various senior positions in what was then the Office of Global Health Affairs in the Office of the Secretary of Health and Human Services.
Mr. Abdoo received a Bachelor of Arts degree from College of the Holy Cross and conducted graduate studies at Brown University. Before entering joining Federal service, he lived in East Asia for nine years, where he owned two consulting companies. He is fluent in Mandarin.
Deputy Director, Office of Global Policy and Strategy
Kristi Hampton is the Deputy Director for the Office of Global Policy and Strategy (OGPS). She has been with the FDA for over 22 years, during which she served in a variety of roles, including several programmatic and technical positions. Previous FDA positions she has held include field investigator with the Office of Regulatory Affairs, compliance officer with the Center for Drug Evaluation and Research (CDER), and various leadership positions such as Associate Director for Operations, Associate Director for Organizational Strategy in CDER’s Office of Compliance, and Senior Advisor for Organizational Excellence in OGPS.
Hampton’s experience ranges from engaging in regulatory enforcement/compliance oversight and policy development to leading crosscutting leadership and organizational excellence initiatives such as change and transition management, strategic planning, organizational culture and employee engagement efforts, leadership training, and leadership/executive coaching. A professional certified coach through the International Coach Federation, she also has a bachelor’s degree in biology, a master’s degree in executive leadership, and a master’s certification in comprehensive evidence-based coaching.
As the Deputy Director of OGPS, Hampton’s responsibility is ensuring that the organization’s strategic and programmatic activities are thriving, while building on the positive momentum that the office has gained toward achieving its strategic priority of fostering an inclusive, supportive, high-performing organization that values people. She also leads the development and implementation of OGPS’ Organizational Excellence Action Plan and guides key crosscutting functions for the office.
Director, Office of Communications, Evaluation, and Logistics
Michael Oehlsen, Ph.D., is director of the Office of Communications, Evaluation, and Logistics (OCEL), which is comprised of three distinct functional teams: Communications, Planning and Evaluation, and Logistical Operations. These teams are responsible for providing the Office of Global Policy and Strategy (OGPS) with overall program and logistical support, strategic plan development and performance measurement, and office, agency, and international communications regarding OGPS achievements and global public health interests.
A U.S. Air Force veteran, Oehlsen began his FDA career in 2003 as a regulatory review chemist in the Division of Manufacturing Technologies (DMT) at the Center for Veterinary Medicine (CVM). During his time in the DMT, he reviewed animal drug applications and was an instructor for the FDA’s pharmaceutical inspectorate Level III drug certification program.
In 2010, Oehlsen transitioned to the CVM’s Office of the Director as Director of International Policy and Logistics, where he oversaw the FDA’s Veterinary Mutual Recognition Agreement work with European Union member states and, later, with the United Kingdom following Brexit. He also led several key bilateral and multilateral international working groups to further harmonize global regulatory policies. While at the CVM, Oehlsen also established the center’s inaugural strategic plan for international programs and was responsible for creating and implementing the CVM’s international tracking system for monitoring, tracking, and evaluating all international activities — a system that was later adopted FDA-wide.
Oehlsen received a bachelor’s degree in chemistry and a Ph.D. in metallo-inorganic medicinal chemistry with a concentration in oncological platinum complexes, both from Virginia Commonwealth University. It was during his Ph.D. program — while working on a cancer drug that had entered into clinical trials — that Oehlsen was first introduced to federal and international drug policy.
Mark Abdoo, Acting Director, Office of Global Operations
Director, Office of Trade and Global Partnerships
Joseph Rieras, J.D., is director of the Office of Trade and Global Partnerships (OTGP). He oversees and leads a broad range of significant, wide-ranging, and complex activities related to the FDA’s trade environment, spearheads FDA’s negotiation, conclusion, and implementation of mutual recognition agreements, and supervises the FDA’s efforts to establish international arrangements, including confidentiality commitments.
Rieras earned his law degree from the Howard University School of Law. He started his career in the private sector as an attorney in the international trade group of a major D.C.-based law firm. He began his public service when he joined the Office of the General Counsel of the Office of the United States Trade Representative (USTR), within the Executive Office of the President. As an Associate General Counsel, Rieras represented the United States in litigation at the World Trade Organization, handled trade-related regulatory policy and legal matters, and was the lead counsel for trade agreement negotiations. He also served as a USTR Legal Advisor in Geneva, Switzerland.